There are just over two months to go until the National Security and Investment (NSI) regime goes fully live in the UK – now is the time to ensure you are up to speed on how it will impact your acquisitions and investments. ...more
The UK’s much publicised National Security and Investment Bill has now been granted Royal Assent – passing into law an Act which will significantly affect the way investments in the UK can be reviewed by the Government where...more
A new National Security and Investment Bill laid before the UK Parliament this week will, on enactment, significantly affect the way investments in the UK can be reviewed by the UK Government where they raise national...more
2/12/2021
/ Covered Transactions ,
Critical Infrastructure Sectors ,
Cross-Border Transactions ,
Foreign Investment ,
Investment ,
Legislative Agendas ,
Merger Controls ,
National Security ,
Regulatory Agenda ,
Small and Medium-Sized Enterprises (SMEs) ,
UK
Foreign direct investment ("FDI") is an important part of the global economy: OECD data indicates that there was USD$1,426 billion of global FDI in 2019. In recent years, governments around the world have shown an increasing...more
New measures, announced on 21 June 2020, will allow the UK Government to intervene in relation to transactions involving businesses with "critical capabilities" to help combat public health emergencies, such as...more
On 20 November 2018, the European Commission (Commission) announced a draft EU framework for screening foreign direct investment (FDI) in response to concerns regarding foreign investment in EU-based businesses active in...more
The UK Government has been consulting on a new regime which will grant it wide powers to intervene in deals on grounds of national security. The consultation period in relation to the Government's proposals has recently...more
Read the latest news on antitrust, competition, and economic regulation in this summer edition of our quarterly ACER newsletter.
...more
9/19/2018
/ Algorithms ,
Anti-Competitive ,
Anti-Steering Rules ,
Antitrust Provisions ,
Antitrust Violations ,
AT&T ,
China ,
Competition ,
Competition Act ,
EU ,
Excessive Pricing ,
False Advertising ,
Foreign Investment ,
Internet Retailers ,
Legislative Agendas ,
Merger Controls ,
Monopolization ,
National Health Service Corp (NHSC) ,
Ohio v American Express ,
Pfizer ,
Pharmaceutical Industry ,
Prescription Drugs ,
Regulatory Oversight ,
Regulatory Standards ,
SCOTUS ,
Single Entity Rule ,
Telecommunications ,
Time Warner ,
UK ,
UK Competition and Markets Authority (CMA) ,
UK Competition Appeal Tribunal (CAT) ,
Unfair or Deceptive Trade Practices